Labor, Premature Clinical Trial
Official title:
Vaginal Ultrasound Cerclage Trial
Pregnant women who have a shortened cervix and have previously had a premature baby are at increased risk for having another premature baby. This study will determine whether reinforcing the cervix with a surgical stitch can reduce the chance of a premature birth.
Women with a prior early spontaneous preterm birth and a shortened mid-trimester cervical
length (less than 25 mm) are at very high risk for having another premature baby. The
Vaginal Ultrasound Cerclage Trial is a multicenter, randomized clinical trial designed to
determine the efficacy of cerclage (a purse-string suture placed around the uterine cervix)
for the prevention of spontaneous preterm birth prior to 35 weeks' gestation. The study will
evaluate women at significant risk for recurrent spontaneous preterm birth (those with a
prior spontaneous birth at 17 to 32 weeks' gestation) and who have an increased risk based
on mid-trimester ultrasound findings of a cervical length less than 25 mm.
The trial will have an observational portion and an interventional portion. In the
observational portion, 1,000 women with a history of a spontaneous preterm birth at 17 to 32
weeks' gestation will undergo biweekly vaginal ultrasounds beginning at 16 to 18 weeks'
gestation and ending by 22 weeks. Prior research indicates that one third of these women
will either have or develop a cervix less than 25 mm long. Women will be seen at a frequency
determined by the cervical length (as determined by ultrasound examination starting at 16
weeks' gestation). If cervical length remains greater than 30 mm, the next visits will occur
in 2 week intervals until 22.6 weeks' gestation. If the cervical length is 25 mm to 29 mm,
the visits will be scheduled weekly. If the cervical length shortens to less than 25 mm, the
woman is eligible for randomization, and will undergo one more study visit.
In the interventional portion of the trial, women will be randomized to either cerclage or
no cerclage (control group). Randomized women will have weekly contact with a nurse either
by phone or in person, whichever is convenient for the woman, until delivery occurs. The
woman is followed during the course of her pregnancy and delivery of her infant. Her infant
is followed until discharge from the hospital.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03171480 -
Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia
|
Phase 4 | |
Completed |
NCT00397735 -
N-acetylcysteine in Intra-amniotic Infection/Inflammation
|
Phase 1/Phase 2 | |
Completed |
NCT00209326 -
A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor
|
Phase 2 | |
Terminated |
NCT03682822 -
Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial
|
N/A | |
Terminated |
NCT00137501 -
Two Dose Regimens of Nifedipine for the Management of Preterm Labor
|
Phase 3 | |
Terminated |
NCT00641784 -
Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population
|
Phase 3 | |
Withdrawn |
NCT01206998 -
Vaginal Progesterone as a Treatment for Women Active Preterm Labor
|
N/A | |
Completed |
NCT00599898 -
Nifedipine Compared to Atosiban for Treating Preterm Labor
|
Phase 4 | |
Completed |
NCT00432250 -
The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor.
|
Phase 4 | |
Terminated |
NCT00116623 -
Magnesium Sulfate Versus Indomethacin for Preterm Labor
|
Phase 4 | |
Not yet recruiting |
NCT04105881 -
Correlation Between Vitamin D and B Regulatory Cell in Pregnancy
|